EURAZEO (EPA:RF) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
EURAZEO

BRIEF

published on 10/08/2024 at 18:26, 1 month 12 days ago

EURAZEO Announces Share and Voting Rights Update

Voting Rights Shares EURAZEO Financial Disclosure AMF Regulation
REGULATED PRESS RELEASE

published on 10/08/2024 at 18:21, 1 month 12 days ago

Disclosure of the number of shares and the total number of voting rights as of September 30, 2024
Disclosure of the number of shares and voting rights of Eurazeo SE as of September 30, 2024 in compliance with French regulations

Voting Rights Shares French Regulations Financial Disclosure Eurazeo SE
REGULATED PRESS RELEASE

published on 10/07/2024 at 17:35, 1 month 13 days ago

Disclosure of transactions in own shares on October 1 to October 4, 2024
BRIEF

published on 10/03/2024 at 08:05, 1 month 18 days ago

Kurma Partners Completes First Close of EUR 250 Million Biofund IV

Investment Venture Capital Therapeutics Kurma Partners Biofund IV
REGULATED PRESS RELEASE

published on 10/03/2024 at 08:00, 1 month 18 days ago

KURMA PARTNERS ACHIEVES FIRST CLOSE OF NEW EUR 250 MILLION BIOFUND IV
Kurma Partners achieves first close of new EUR 250 million biofund IV, aiming for 16-20 new investments and leveraging successful Biofund III portfolio. Key investors include Eurazeo and CSL

Investment Fund Health Innovation Kurma Partners Biofund IV EUR 250 Million
BRIEF

published on 10/01/2024 at 18:05, 1 month 19 days ago

EURAZEO Announces Sale of 22 Hotels by Grape Hospitality

EURAZEO Real Estate Strategy Hotel Sale Grape Hospitality France Hotels
REGULATED PRESS RELEASE

published on 10/01/2024 at 18:00, 1 month 19 days ago

EURAZEO ANNOUNCES THE SALE OF 22 HOTELS BY GRAPE HOSPITALITY
Eurazeo announces sale of 22 hotels by Grape Hospitality in France to a consortium, focusing on upscale market segments, highlighting operational and asset management expertise

EURAZEO Asset Management Hotel Sale Grape Hospitality Upscale Segment
REGULATED PRESS RELEASE

published on 09/30/2024 at 18:49, 1 month 20 days ago

Disclosure of transactions in own shares on September 23 to September 30, 2024
REGULATED PRESS RELEASE

published on 09/23/2024 at 17:35, 1 month 27 days ago

Disclosure of transactions in own shares on September 16 to September 20, 2024
REGULATED PRESS RELEASE

published on 09/16/2024 at 17:35, 2 months 4 days ago

Disclosure of transactions in own shares on September 9 to September 13, 2024

Accesswire

Published on 11/21/2024 at 13:30, 25 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 25 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 55 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 55 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 55 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 40 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 20 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 40 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 49 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 55 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 57 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 35 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE